# Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus

> **NCT05043467** · — · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 2228 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

- **DRUG:** Duvie(Lobeglitazone) tab 0.5mg

## Key facts

- **NCT ID:** NCT05043467
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-02
- **Primary completion:** 2020-06-19
- **Final completion:** 2020-06-19
- **Target enrollment:** 2228 (ACTUAL)
- **Last updated:** 2021-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05043467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05043467, "Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05043467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*